Federal Scientists Confirm Medicinal Benefits of Weed and Support Reclassification In a groundbreaking development, federal scientists have confirmed the medicinal...
Newly Launched Biotech Secures $135 Million Funding for Pain Medication to Compete with Vertex In a significant development for the...
Avanos Medical, Inc., a leading medical technology company, has recently announced that it will be hosting a webcast conference call...
Orexa Commences Phase 2 Trial in Post-Operative Patients with First Patient Dosed – Drugs.com MedNews Orexa Pharmaceuticals, a leading biopharmaceutical...
CBD, short for cannabidiol, has gained significant popularity in recent years for its potential health benefits. One of the most...
Advocate Groups in Kansas Rally for the Legalization of Medical Cannabis In recent years, the debate surrounding the legalization of...
The Pill Problem at Trump’s White House Pharmacy In recent years, the United States has been grappling with a growing...
Vanderbilt chemist Ben Brown receives $2.375M grant for the development of nonaddictive substances In a world grappling with the devastating...
FDA Clears Non-Invasive Treatment for Painful Diabetic Neuropathy, Marked as Pioneering Diabetic neuropathy is a common complication of diabetes that...
The Impact of a Burst Water Pipe on the City: Brown Water Floods CBD and its Connection to the Medical...
UFC Approves the Use of Cannabis In a groundbreaking move, the Ultimate Fighting Championship (UFC) has recently announced its approval...
The reintroduction of a medical marijuana bill in the Wisconsin Assembly has sparked both hope and uncertainty among advocates and...
Title: Top Cannabis Strains for Pain Relief and Insomnia in 2024 Introduction: As the cannabis industry continues to evolve, more...
Increase in Fatalities Linked to Counterfeit Xanax Surges, Reports Drugs.com MedNews Counterfeit drugs have become a growing concern in recent...
Avanos Medical, Inc., a leading medical technology company, recently announced its preliminary financial results for the fourth quarter and full-year...
